Examkin

Question

Difficulty: Very hardEndocrinology and Metabolism

A 48-year-old man presents to the clinic reporting progressive enlargement of his hands and feet over the past 44 years. He recently had to resize his wedding ring and notes that his shoes no longer fit. He also complains of increased sweating, joint pain, and frequent frontal headaches. His wife mentions that his jaw has become more prominent and there are new gaps between his teeth. His blood pressure is 165/95165/95 mmHg. Arrange the following steps in the most appropriate chronological order for the diagnostic workup and initial definitive management of this patient's suspected condition.

  1. 1Measure serum insulin-like growth factor 1 (IGF-1) concentration
  2. 2Perform an oral glucose tolerance test (OGTT) with measurement of serum growth hormone (GH)
  3. 3Obtain a magnetic resonance imaging (MRI) scan of the brain with focus on the sella turcica
  4. 4Perform formal visual field perimetry testing
  5. 5Proceed with transsphenoidal adenomectomy

Answer

The correct sequence for the evaluation and management of suspected acromegaly is: (1) Measure serum IGF-1, (2) Perform an OGTT with GH measurement, (3) Obtain a pituitary MRI, (4) Perform visual field testing, and (5) Proceed with transsphenoidal surgery.
The diagnostic algorithm for acromegaly requires proving biochemical excess before anatomical localization. Due to the pulsatile nature of growth hormone (GH), random GH levels are clinically useless. Therefore, the most appropriate initial screening test is measuring insulin-like growth factor 1 (IGF-1), which reflects average GH levels over days. If IGF-1 is elevated, autonomous GH secretion must be confirmed dynamically. The gold standard confirmatory test is the oral glucose tolerance test (OGTT); normally, a glucose load suppresses GH, but in acromegaly, GH remains unsuppressed. Only after biochemical confirmation should anatomical localization with a pituitary MRI be pursued. Because GH-secreting tumors are often macroadenomas (>10 mm) that can compress the optic chiasm, formal visual field perimetry is a necessary preoperative step to document deficits such as bitemporal hemianopsia. Finally, the first-line definitive treatment is surgical resection via a transsphenoidal approach.

Step-by-Step Solution

1
Measure serum IGF-1 concentration.
Serves as the initial screening test.
Growth hormone (GH) secretion is highly pulsatile, making random GH levels unreliable. IGF-1 provides a stable reflection of integrated GH secretion over time.
2
Perform OGTT with GH measurement.
Serves as the confirmatory biochemical test.
Normal physiology dictates that a glucose load suppresses GH. Failure to suppress GH definitively confirms the autonomous hypersecretion seen in acromegaly.
3
Obtain pituitary MRI.
Localizes the pituitary tumor.
Once the disease is biochemically confirmed, imaging is required to visualize the adenoma (which is usually a macroadenoma) before any physical intervention.
4
Perform formal visual field perimetry.
Assesses for optic chiasm compression.
Given the patient's headaches and the high likelihood of a macroadenoma, assessing for bitemporal hemianopsia is a critical preoperative step for surgical planning.
5
Proceed with transsphenoidal adenomectomy.
Provides definitive management.
Surgical resection is the first-line definitive treatment for GH-secreting pituitary adenomas, alleviating both hormone excess and mass effect.

Key Concept

The diagnostic algorithm for acromegaly dictates biochemical confirmation of autonomous hormone excess prior to anatomical imaging to avoid diagnostic confusion from incidentalomas.
Estimated Time:1m 30s
Rate this question

Topics

Endocrinology and Metabolism

More questions from this topic